Evidence map›Paper›PMID 38902287›Full record

ArticleScientific reports2024

Hybrid transformer-CNN model for accurate prediction of peptide hemolytic potential.

Sultan Almotairi, Elsayed Badr, Ibrahim Abdelbaky, Mohamed Elhakeem, Mustafa Abdul Salam

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sultan AlmotairiDepartment of Computer Science, Faculty of College of Computer and Information Sciences, Majmaah University, 11952, Majmaah, Saudi Arabia.
Elsayed BadrScientific Computing Department, Faculty of Computers and Artificial Intelligence, Benha University, Benha, Egypt. alsayed.badr@fci.bu.edu.eg.
Ibrahim AbdelbakyArtificial Intelligence Department, Faculty of Computers and Artificial Intelligence, Benha University, Benha, Egypt.
Mohamed ElhakeemArtificial Intelligence Department, Faculty of Computers and Artificial Intelligence, Benha University, Benha, Egypt. mohamed.abdelhady@fci.bu.edu.eg.
Mustafa Abdul SalamArtificial Intelligence Department, Faculty of Computers and Artificial Intelligence, Benha University, Benha, Egypt.

Funding

Majmaah University R-2023-629
6 · The paper itself

Abstract

Hemolysis is a crucial factor in various biomedical and pharmaceutical contexts, driving our interest in developing advanced computational techniques for precise prediction. Our proposed approach takes advantage of the unique capabilities of convolutional neural networks (CNNs) and transformers to detect complex patterns inherent in the data. The integration of CNN and transformers' attention mechanisms allows for the extraction of relevant information, leading to accurate predictions of hemolytic potential. The proposed method was trained on three distinct data sets of peptide sequences known as recurrent neural network-hemolytic (RNN-Hem), Hlppredfuse, and Combined. Our computational results demonstrated the superior efficacy of our models compared to existing methods. The proposed approach demonstrated impressive Matthews correlation coefficients of 0.5962, 0.9111, and 0.7788 respectively, indicating its effectiveness in predicting hemolytic activity. With its potential to guide experimental efforts in peptide design and drug development, this method holds great promise for practical applications. Integrating CNNs and transformers proves to be a powerful tool in the fields of bioinformatics and therapeutic research, highlighting their potential to drive advancement in this area.

Indexed as

HemolysisNeural Networks, ComputerPeptidesComputational BiologyHumansPeptidesConvolutional neural networks (CNNs)Deep learningDrug designHemolysisHemolytic predictionPeptidesTransformers

Identifiers

PMID38902287
PMCPMC11190137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.